HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2011

Feb 22, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2011-02-16

Reporting Person: DAVIS STEPHEN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-16	Common Stock	J	31088	—	Disposed	95891	Direct

Footnotes

F1: Restricked stock award cancelled effective February 16, 2011.